PSORIASIS TREATMENT IN PEDIATRIC AGE – PART I: TOPICAL TREATMENT

  • Maria João Cruz Serviço de Dermatologia e Venereologia do Hospital de São João
  • Sofia Magina Serviço de Dermatologia e Venereologia do Hospital de São João; Faculdade de Medicina da Universidade do Porto
  • Teresa Baudrier Serviço de Dermatologia e Venereologia do Hospital de São João
  • Filomena Azevedo Serviço de Dermatologia e Venereologia do Hospital de São João
Keywords: Psoriasis, Child, Topics, Treatment

Abstract

Psoriasis is a chronic inflammatory disorder, multisystem and immunologically mediated. Approximately one third of adults refer the age of onset before 16, representing about 4% of all dermatoses seen in pediatric age. The majority of cases are mild and adequately managed with topical medications. A minor subset of children present with severe, rapidly evolving disease that requires systemic therapy. The use of these therapies is limited by the risk of toxicity, the low acceptance and lack of studies to validate and guide the use of most of these drugs in children. This is the first of two articles which aim to review the topical (Part I) and systemic (Part II) treatment options available, as well as its safety and efficacy in children.

Downloads

Download data is not yet available.
Published
2016-11-23
How to Cite
Cruz, M. J., Magina, S., Baudrier, T., & Azevedo, F. (2016). PSORIASIS TREATMENT IN PEDIATRIC AGE – PART I: TOPICAL TREATMENT. Journal of the Portuguese Society of Dermatology and Venereology, 69(1), 25-31. https://doi.org/10.29021/spdv.69.1.632
Section
Original Articles